October 26, 2020

Innovative Medicines Canada Statement Regarding the Potential Disclosure of Proprietary or Commercially-Sensitive Business Information

Ottawa, October 23, 2020—Innovative Medicines Canada (IMC) issued the following statement in response to the potential disclosure of proprietary or confidential business information regarding the procurement of COVID-19 medicines and […]

October 23, 2020

Innovative Medicines Canada responds to release of Patented Medicine Prices Review Board’s (PMPRB) final Guidelines

STATEMENT Ottawa, October 23, 2020 – Innovative Medicines Canada (IMC) issued the following statement today in response to the release of PMPRB’s final Guidelines: “For the last five years we have […]

September 28, 2020

Innovative Medicines Canada responds to the Trump administration’s plan to allow the importation of prescription drugs from Canada

STATEMENT Ottawa, September 25, 2020 – The following statement can be attributed to Declan Hamill, Vice President, Legal, Regulatory Affairs & Compliance, Innovative Medicines Canada in response to the Trump […]

September 23, 2020

Innovative Medicines Canada responds to today’s Speech from the Throne

STATEMENT Ottawa, September 23, 2020 – Pamela Fralick, President of Innovative Medicines Canada, issued the following statement in response to today’s Speech from the Throne: “COVID-19 has shown just how […]

September 7, 2020

Hope is Hard Work.

Our members have never shied away from doing whatever it takes — because it is worth it to provide hope to people when they need it most.